Skip to main content
. 2020 Jun 16;4:PO.20.00069. doi: 10.1200/PO.20.00069

FIG 3.

FIG 3.

Association of fraction of genome altered (FGA) with response to immune checkpoint inhibitor (ICI) and survival. (A) FGA by response to ICI (left: overall cohort, right: high-grade serous ovarian cancer [HGSOC] only). (B) Association of FGA with progression-free survival (PFS; left) and overall survival (OS; right) in all overall cancer. Log-rank P values are shown. (C) Association of FGA with PFS (left) and OS (right) in the HGSOC subset only. Log-rank P values are shown. Cutoff of 34%, derived using maximally selected standardized log-rank statistic, was used for survival analysis.